| First Author | Lin Y | Year | 2019 |
| Journal | Commun Biol | Volume | 2 |
| Pages | 378 | PubMed ID | 31633069 |
| Mgi Jnum | J:281932 | Mgi Id | MGI:6380939 |
| Doi | 10.1038/s42003-019-0607-z | Citation | Lin Y, et al. (2019) Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. Commun Biol 2:378 |
| abstractText | Metabolism is a major defense mechanism of the body against xenobiotic threats. Here we unravel a critical role of Bmal1 for circadian clock-controlled Cyp3a11 expression and xenobiotic metabolism. Bmal1 deficiency decreases the mRNA, protein and microsomal activity of Cyp3a11, and blunts their circadian rhythms in mice. A screen for Cyp3a11 regulators identifies two circadian genes Dbp and Hnf4alpha as potential regulatory mediators. Cell-based experiments confirm that Dbp and Hnf4alpha activate Cyp3a11 transcription by their binding to a D-box and a DR1 element in the Cyp3a11 promoter, respectively. Bmal1 binds to the P1 distal promoter to regulate Hnf4alpha transcriptionally. Cellular regulation of Cyp3a11 by Bmal1 is Dbp- and Hnf4alpha-dependent. Bmal1 deficiency sensitizes mice to toxicities of drugs such as aconitine and triptolide (and blunts circadian toxicity rhythmicities) due to elevated drug exposure. In summary, Bmal1 connects circadian clock and Cyp3a11 metabolism, thereby impacting drug detoxification as a function of daily time. |
